Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto in Diastolic Dysfunction After AMI
NCT04149990Phase 2Terminated
- Start
- Oct 2018
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sacubitril + valsartan in diastolic dysfunction. Started Oct 2018; status: terminated.
02
Drugs
sacubitril + valsartan
03
Conditions
diastolic dysfunction
Beyond the preview
Go deeper on NCT04149990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04149990.